# Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease

> **NCT06543563** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 102 (estimated)

## Conditions studied

- PD - Parkinson's Disease
- Deep Brain Stimulation
- Esketamine

## Interventions

- **DRUG:** esketamine
- **DRUG:** normal Saline

## Key facts

- **NCT ID:** NCT06543563
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-09
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06543563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06543563, "Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06543563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*